Breast Cancer
Conference Coverage
‘Large benefit’ in ovarian function suppression for breast cancer
Absolute gain for adding ovarian function suppression to tamoxifen increases with longer follow-up.
Conference Coverage
Neighborhood analysis links breast cancer outcomes to socioeconomic status
“This study should make clinicians cognizant of the potential for biases in management of metastatic breast cancer in terms of socioeconomic...
Conference Coverage
For cancer prevention, not all plant-based diets are equal
“The best plant-based diet for breast cancer prevention could be a healthy plant-based diet comprising fruit, vegetables, whole grains, nuts, and...
Conference Coverage
Breast cancer deaths take a big dip because of new medicines
Research model suggests a 58% overall mortality decline in 2019 from metastatic breast cancer.
Conference Coverage
Excess weight may ward off infection in breast cancer treatment
The study demonstrated significantly less frequent and less severe neutropenia in overweight and obese patients.
Conference Coverage
Women with HER2+ metastatic breast cancer are living longer
Overall survival improved 5.6% each year among over 5,000 patients in the study.
Conference Coverage
Treating bone loss ups survival for breast cancer patients
Findings suggest a trend toward reduction in contralateral breast cancer in the treatment group.
Conference Coverage
Pembrolizumab before surgery improves survival in early triple negative breast cancer
Treatment shifts residual cancer burden to lower categories.
Conference Coverage
New treatment outperforms chemo in HER2-low breast cancer
The results may cause clinicians to reconsider how they define HER2 expression in breast cancer.
News
Metformin bombs in breast cancer in landmark trial
“Metformin is not effective against the most common types of breast cancer and any off-label use [of] this drug for the treatment of these common...